Compliance of Therapeutic Regimen among Patients with Multiple Sclerosis

People with multiple sclerosis (MS) face challenges complying with disease-modifying drug (DMD) treatment. Poor compliance with treatment reduces its clinical effectiveness which can adversely impact disease progression, MS-related hospitalization.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:NeuroQuantology 2022-01, Vol.20 (11), p.8196
Hauptverfasser: Dina Mohamed Mohamed Abdallah, Nadia Mohamed Taha, Elham Hamd Mohamed Hamd, saleh, Maha Desoky
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:People with multiple sclerosis (MS) face challenges complying with disease-modifying drug (DMD) treatment. Poor compliance with treatment reduces its clinical effectiveness which can adversely impact disease progression, MS-related hospitalization.
ISSN:1303-5150
DOI:10.14704/NQ.2022.20.11.NQ66812